We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Inspection of Similasan's Switzerland Plant Leads to Warning Letter
Inspection of Similasan's Switzerland Plant Leads to Warning Letter
October 3, 2005
Swiss drugmaker Similasan AG has received an FDA warning letter for failing to meet cGMP requirements in its manufacture of two eye drop products.